RCM
ARRY

RA Capital Management’s Array Biopharma Inc ARRY Stock Holding History

RA Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-126,095
Closed -$909K – 70
2015
Q2 		$909K Sell
126,095
-1,231,489
-91% -$9.09M 0.09% 55
2015
Q1 		$10M Buy
+1,357,584
New +$9.66M 0.99% 24

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RA Capital Management's ARRY Position: Q3 2015 in Review

RA Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2015, closing a stake of 126,095 shares — an estimated $909K sold.

RA Capital Management first reported a position in ARRY in Q1 2015 and held it in 2 quarters. The position peaked at $10M in Q1 2015. 157 funds tracked by Wall St. Rank hold ARRY as of Q3 2015.

  • RA Capital Management reported no remaining Array Biopharma Inc position as of Q3 2015 after selling out during the quarter.
  • RA Capital Management sold 126,095 Array Biopharma Inc shares in Q3 2015, an estimated $909K.
  • RA Capital Management first reported a position in Array Biopharma Inc in Q1 2015 and held it in 2 quarters.
  • RA Capital Management's Array Biopharma Inc position peaked at $10M in Q1 2015.
  • 157 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2015.

Based on RA Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.